Our client, an international pharmaceutical company specialising in Oncology, wanted to gain a deeper understanding of the unmet needs and concerns of patients living with Mantle Cell Lymphoma (MCL). They sought to clarify how stakeholders’ discussions varied by the different phases of the patient journey in regards to causes, symptoms, diagnosis, treatment and maintenance.

For a holistic and nuanced view of MCL as a therapeutic area, the client also wanted to analyse the conversations and interactions by caregivers and HCPs. Supported by third-party qualitative research, our findings and insights helped the client create messaging tailored to each journey stage and stakeholder group.